This guide is for consultant pharmacists, clinical pharmacy directors, and the skilled nursing facility (SNF) leaders who own survey outcomes with them: Directors of Nursing (DON), administrators, and compliance officers. You will get a practical framework for nursing home pharmacy survey preparation — what surveyors tend to scrutinize, how the monthly medication regimen review (MRR) feeds survey readiness, and how to keep documentation defensible year-round rather than scrambling in the days before surveyors arrive.
Why pharmacy is a recurring survey focus
Medication-related deficiencies are among the most consistently cited areas in long-term care surveys. The Centers for Medicare & Medicaid Services (CMS) ties several F-tags to pharmacy services, drug regimen review, unnecessary drugs, and psychotropic use, and state survey agencies enforce them during standard and complaint surveys.
Rather than memorize tag numbers, understand the intent behind them. Surveyors are evaluating whether each resident's medication regimen is clinically appropriate, monitored, and free of unnecessary drugs — and whether the facility acted on the consultant pharmacist's findings. For the current, authoritative list of F-tags and interpretive guidance, consult the State Operations Manual and related guidance published at cms.gov; these are periodically updated.
What surveyors typically examine
Survey scope varies, but pharmacy-related review commonly touches these areas. Treat this as a preparation checklist, not a substitute for the official interpretive guidance.
- Monthly MRR completion. Evidence that a licensed pharmacist reviewed each resident's regimen on schedule, with documented findings.
- Irregularity reporting and follow-up. That identified irregularities were communicated to the attending prescriber and the medical director, and that the facility responded — acceptance, rejection with rationale, or a change order.
- Unnecessary drug review. Documentation supporting indication, dose, duration, and monitoring, and attention to potentially inappropriate medications in older adults.
- Psychotropic and antipsychotic use. Documented indication, informed consent where applicable, monitoring, and consideration of gradual dose reduction (GDR) or a clinical rationale for why GDR is not attempted.
- Controlled substance handling. Storage, reconciliation, disposal, and recordkeeping consistent with state board of pharmacy and Drug Enforcement Administration (DEA) requirements.
- Consultant pharmacist reports. Timeliness, signature, and the facility's system for tracking recommendations to closure.
Build a year-round readiness posture
The facilities that survey well do not prepare for a survey; they operate in a state of readiness. Use these principles to make documentation continuously defensible.
1. Standardize the MRR trail
Every monthly review should produce a dated, signed record that shows what was evaluated and what was recommended. The consultant pharmacist evaluates whether each medication has a supportable indication, appropriate monitoring, and no duplication — and the record should reflect that reasoning, not just a checkbox.
2. Close the loop on every recommendation
An open recommendation with no documented disposition is a common vulnerability. Track each irregularity from identification to prescriber response so a surveyor can follow the thread without asking. Where a prescriber declines a recommendation, the clinical rationale belongs in the record.
3. Apply current clinical criteria — and cite the source
Consultant pharmacists commonly draw on the American Geriatrics Society (AGS) Beers Criteria, STOPP/START, and anticholinergic burden (ACB) concepts to identify potentially inappropriate medications in older adults. These tools flag risk; they do not dictate care. The pharmacist applies professional judgment to each resident, and the facility should be able to show that judgment was exercised. Because these criteria are revised periodically, work from the current published version.
4. Keep psychotropic documentation tight
Antipsychotic and other psychotropic use draws heightened survey attention. Ensure indication, target symptoms, monitoring, and GDR consideration are documented. When GDR is clinically contraindicated, the record should say why.
5. Reconcile controlled substances continuously
Maintain reconciliation, secure storage, and disposal records aligned to your state board of pharmacy rules and DEA requirements. Do not let this become a quarterly cleanup task.
A 30-day pre-survey checklist
When your survey window approaches, use a focused sweep to catch gaps before a surveyor does.
- Verify MRR completeness. Confirm every current resident has a documented, signed review for each required period, with no missing months.
- Audit open recommendations. Identify any irregularity without a prescriber disposition and resolve or document it.
- Spot-check psychotropic records. Confirm indication, consent where applicable, monitoring, and GDR documentation.
- Review high-risk medications. Re-examine regimens flagged by Beers, STOPP/START, or ACB screening for documented clinical rationale.
- Reconcile controlled substances. Confirm counts, storage, and disposal records are current and complete.
- Confirm signatures and dates. Ensure consultant reports are signed and that the facility's acknowledgment is captured.
- Assemble the report bundle. Have MRR summaries, recommendation logs, and policies retrievable on request.
Common findings you can prevent
Most pharmacy-related citations trace back to a handful of avoidable patterns: reviews completed but not signed, recommendations made but never tracked to a disposition, psychotropic use without documented monitoring or GDR consideration, and inconsistent controlled-substance records. Each is a documentation and workflow problem more than a clinical one — which means a disciplined, standardized process closes most of the exposure.
Make the record retrievable
Survey day is a retrieval test. Surveyors ask for specific records and expect them quickly. If your MRR findings, recommendation dispositions, and sign-offs live across paper binders, faxes, and email, retrieval is slow and gaps are hard to see. A single, searchable, append-only record of who reviewed what, when, and how it was resolved turns a stressful request into a two-minute pull. For how WeConsultRx approaches data protection and transparency, see our trust center.
How WeConsultRx helps
WeConsultRx compliance automation is built for exactly this workflow. The platform maps consultant findings to CMS F-tag concepts, supports state-board filing documentation, captures e-signature sign-off on every review, and preserves an append-only, 7-year audit log so every recommendation and its disposition are retrievable on demand. That means your nursing home pharmacy survey preparation becomes a continuous state rather than a fire drill. Explore the clinical engine and report bundles, or request a demo to see the audit trail in action. Always confirm current requirements against the official CMS and state board sources, since regulations and clinical criteria are updated periodically.